+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Acetylcholine"

Generalized Myasthenia Gravis (gMG) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Generalized Myasthenia Gravis (gMG) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2022
  • 182 Pages
  • Global
From
Generalized Myasthenia Gravis (gMG) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Generalized Myasthenia Gravis (gMG) - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 91 Pages
  • Global
From
Asia Pacific Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • November 2023
  • 116 Pages
  • Asia Pacific
From
Muscarinic Acetylcholine Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Muscarinic Acetylcholine Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • September 2024
  • 81 Pages
  • Global
From
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 67 Pages
  • Global
From
Neuronal Acetylcholine Receptor Subunit Beta 2 - Pipeline Review, H2 2020 - Product Thumbnail Image

Neuronal Acetylcholine Receptor Subunit Beta 2 - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 60 Pages
  • Global
From
Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 49 Pages
  • Global
From
Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 48 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M2 (CHRM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M2 (CHRM2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 61 Pages
  • Global
From
Neuronal Acetylcholine Receptor Subunit Alpha 3 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Neuronal Acetylcholine Receptor Subunit Alpha 3 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 35 Pages
  • Global
From
Neuronal Acetylcholine Receptor Subunit Beta 4 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Neuronal Acetylcholine Receptor Subunit Beta 4 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 36 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 64 Pages
  • Global
From
Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 10 - Product Thumbnail Image

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 10

  • Book
  • April 2022
Italy Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Italy Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • May 2023
  • 80 Pages
  • Italy
From
Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • April 2023
  • 263 Pages
  • Global
From
Dementia Drugs Market By Indication, By Drug Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Dementia Drugs Market By Indication, By Drug Class, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • October 2022
  • 265 Pages
  • Global
From
Botulinum Toxin Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Botulinum Toxin Market By Product, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • October 2022
  • 215 Pages
  • Global
From
Loading Indicator

The Acetylcholine market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Acetylcholine is a neurotransmitter that plays a role in muscle contraction, memory, and learning. It is used to treat conditions such as Alzheimer's disease, Parkinson's disease, and myasthenia gravis. Acetylcholine is available in both oral and injectable forms, and is often used in combination with other drugs. The Acetylcholine market is highly competitive, with many companies offering products. Some of the major players in the market include Pfizer, Novartis, Merck, GlaxoSmithKline, and Sanofi. Other companies include Allergan, Teva Pharmaceuticals, and Mylan. Show Less Read more